N-Nitroso Benserazide
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. The primary therapeutic use for which benserazide is currently indicated for is as a combination therapy with levadopa for the treatment of Parkinson's disease in adults > 25 years of age, with the exception of drug-induced parkinsonism.Benserazide Nitroso is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Benserazide Nitroso CAS NO:NA also known as N-Nitroso Benserazide chemically represented as N'-Seryl-N-(2,3,4-trihydroxybenzyl)nitrous hydrazide. Synchemia is the leading manufacturing and exporter of Benserazide Nitroso.We supply Benserazide Nitroso with detailed characterization data compliance with regulatory guidelines.